However, simultaneous deletion of both murine Zeb2 and Zeb1 in murine MLL-AF9 AML settings was found to significantly increase the overall survival of mice transplanted with MLL-AF9 secondary tumor cells compared with nontreated vehicle-treated controls [130]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.